Centrexion

Latigo Biotherapeutics

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.

Mimetic Medicines

This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.

Latigo

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.

Graviton Bioscience Corporation

The company develops small-molecule therapeutics targeting autoimmune, fibrotic and central nervous system diseases for patients with unmet medical needs.

CeNeRx

This biopharmaceutical company develops clinical-stage therapeutics for central nervous system disorders, such as depression and pain, for patients and healthcare providers.

Brixton Biosciences

This life sciences company develops a nerve-selective injectable biomaterial that provides long-lasting, drug-free pain relief for patients suffering from chronic and acute orthopedic conditions.

Vapogenix

Vapogenix develops topical non-opioid analgesics to treat localised pain from wounds and inflammatory conditions for patients requiring non-narcotic relief.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.